Location History:
- Faches-Thumesnti, FR (2007)
- Faches Thumesnil, FR (2010 - 2012)
Company Filing History:
2 out of 32 
1 out of 1 Years Active: 2007-2012
Title: Igor Razdobreev: Innovator in Medical Technology
Introduction
Igor Razdobreev is a notable inventor based in Faches Thumesnil, France. He has made significant contributions to the field of medical technology, particularly in the treatment of age-related macular degeneration. With a total of 3 patents to his name, Razdobreev's work showcases his dedication to advancing healthcare solutions.
Latest Patents
Among his latest patents is an "Apparatus for treating age-related macular degeneration (ARMD)." This innovative device includes a light source that emits a therapeutic light beam with an emission wavelength ranging from 1.2 μm to 1.3 μm, specifically targeting wavelengths of 1.26 μm to 1.27 μm. The apparatus utilizes an optical fiber Raman laser to deliver its therapeutic effects. Another significant patent is for an "Apparatus for treating age-related maculopathy (ARM)," which shares similar features and functions as the ARMD apparatus, emphasizing the importance of light therapy in treating these conditions.
Career Highlights
Igor Razdobreev has worked with esteemed institutions such as the Université des Sciences et Technologies de Lille. His experience in these research environments has allowed him to develop and refine his innovative medical devices, contributing to the advancement of treatment options for patients suffering from vision-related ailments.
Collaborations
Throughout his career, Razdobreev has collaborated with talented individuals, including Jaouad Zemmouri and Andrey Kurkov. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Igor Razdobreev's contributions to medical technology, particularly in the treatment of age-related macular degeneration, highlight his innovative spirit and commitment to improving patient care. His patents reflect a significant advancement in therapeutic techniques, showcasing the potential for light-based treatments in ophthalmology.